ArticleBMC gastroenterology2021

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study.

Yue Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.